Luminal A tumors (estrogen receptors (ER)+, progesterone receptors (PR)+) are typically characterized by the best prognosis [4], whereas TNBC, which lacks the expression of ER, PR, and HER2, frequently correlates with the poorest prognosis [5]. This evidence concerns the gene ESR1 and luminal A breast carcinoma.